Literature DB >> 11511119

Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.

B L Gerber1, F F Ordoubadi, W Wijns, J L Vanoverschelde, M J Knuuti, M Janier, P Melon, P K Blanksma, A Bol, J J Bax, J A Melin, P G Camici.   

Abstract

AIMS: To assess the accuracy of positron emission tomography to predict recovery of global cardiac function after revascularization in patients with coronary artery disease. METHODS AND
RESULTS: One hundred and seventy-eight patients (157 male, 58+/-10 years) with coronary artery disease and left ventricular dysfunction (mean ejection fraction 39+/-14%) were enrolled in six European centres. They underwent a common protocol for the assessment of viability using(18)F-fluoro-2-deoxyglucose (FDG) positron emission tomography during a standardized euglycaemic hyperinsulinaemic glucose clamp before revascularization by either surgery (n=140) or angioplasty (n=38). Seven patients were excluded because of incomplete revascularization of a dysfunctional region. Based on the recovery of global ejection fraction 2-6 months after revascularization, patients were classified into two groups: 82 patients who had a >5% improvement in ejection fraction postoperatively, and 89 patients without postoperative ejection fraction improvement. Optimal cut-off points for postoperative improvement of global cardiac function were computed, using receiver operating curve analysis. The highest sensitivity (79%) and specificity (55%) for predicting postoperative ejection fraction improvement by positron emission tomography was found when three or more dysfunctional segments had a relative FDG uptake >45% of normal remote myocardium (overall accuracy 67%).
CONCLUSIONS: In a large cohort of coronary patients with impaired ejection fraction, FDG positron emission tomography demonstrated high sensitivity and moderate specificity to predict improvement of cardiac function after coronary revascularization. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511119     DOI: 10.1053/euhj.2000.2585

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  29 in total

1.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 2.  Positron emission tomography in acute coronary syndromes.

Authors:  Leonarda Galiuto; Lazzaro Paraggio; Alberto R De Caterina; Elisa Fedele; Gabriella Locorotondo; Lucia Leccisotti; Alessandro Giordano; Antonio G Rebuzzi; Filippo Crea
Journal:  J Cardiovasc Transl Res       Date:  2011-12-15       Impact factor: 4.132

3.  Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.

Authors:  Rene Nkoulou; Aju P Pazhenkottil; Ronny R Buechel; Lars Husmann; Ines Valenta; Bernhard A Herzog; Mathias Wolfrum; Jelena R Ghadri; Philipp A Kaufmann
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-08       Impact factor: 2.357

Review 4.  Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment.

Authors:  M Pakkal; V Raj; G P McCann
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Assessment of myocardial viability: more than measurements of radiotracer uptake alone.

Authors:  James A Arrighi
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 6.  Non-invasive imaging of microvascular damage.

Authors:  L Galiuto; L Natale; L Leccisotti; G Locorotondo; A Giordano; L Bonomo; F Crea
Journal:  J Nucl Cardiol       Date:  2009-08-25       Impact factor: 5.952

7.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

8.  Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Authors:  Haruhisa Shirasaki; Akira Nakano; Hiroyasu Uzui; Yoshiharu Yonekura; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

9.  Pulse pressure variation and volume responsiveness during acutely increased pulmonary artery pressure: an experimental study.

Authors:  Fritz Daudel; David Tüller; Stefanie Krähenbühl; Stephan M Jakob; Jukka Takala
Journal:  Crit Care       Date:  2010-06-24       Impact factor: 9.097

10.  Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.

Authors:  Johannes Boehm; Felix Haas; Robert Bauernschmitt; Stefan Wagenpfeil; Bernhard Voss; Markus Schwaiger; Rüdiger Lange
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-21       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.